MedTrace Logo

The Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome

NCT03268733 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-08-31

No results posted yet for this study

Summary

An open clinical trial

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

Folic Acid

Tablet 5 mg

Sponsors & Collaborators

  • Awad, Mohamed Ibrahim, M.D.

    collaborator INDIV

  • Duria abdulwahab Elrrayes

    collaborator UNKNOWN

  • University of Khartoum

    lead OTHER

Principal Investigators

  • Mohammed Hassan Alnazeer · University of Khartoum

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2018-09-01
Completion
2019-09-01

Countries

  • Sudan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03268733 on ClinicalTrials.gov